跳至主要内容
临床试验/NCT05550805
NCT05550805已完成不适用

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

Qilu Hospital of Shandong University1 个研究点 分布在 1 个国家目标入组 5,822 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,822
试验地点
1
主要终点
major adverse cardiovascular events

研究概览

简要总结

To investigate whether there were differences in metabolomics and lipidomics in patients with coronary artery disease who had major adverse cardiovascular events during follow-up compared with those who did not.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hospitalized patients with the diagnosis of any type of coronary artery disease;
  • Age ≥18 years of age;
  • Patient or guardian provided informed written consent.

排除标准

  • Prior surgery, trauma or clinically evident coagulopathic bleeding within the previous 2 weeks;
  • Bipass population with missing follow-up records in Qilu Hospital emergency follow-up cohort.

结局指标

主要结局

major adverse cardiovascular events

时间窗: 20191101-20220701

cardiac death, myocardial infarction, heart failure, stroke

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验